双极性患者的雷米马佐拉姆诱导的悖论反应:一个病例报告
Zhifu Zhao1, Li Liu1, Xianjie Zhang1
1Department of Anesthesia Deyang People's Hospital Deyang China.
Clinical case reports
|December 15, 2025
概括
这项研究报告了第一个对双相情感障碍患者对雷米马佐拉姆产生悖论反应的病例. 弗卢马泽尼尔成功地逆转了这些二胺诱导的症状,这表明该人群应该谨慎.
科学领域:
- 麻醉学 麻醉学
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 二类药物通常用于手术镇静.
- 矛盾反应 (PR) 是罕见但严重的不良事件.
- 双极性障碍患者可能对GABAergic药物有独特的反应.
研究的目的:
- 在患有双相情感障碍的患者中报告第一个雷米马佐拉姆诱导的悖论反应 (PR) 病例.
- 调查GABAergic功能障碍在PR风险中的潜在作用.
- 评估flumazenil在逆转remimazolam诱导的PR中的疗效.
主要方法:
- 一个患有双相情感障碍的患者的病例报告,他发展了PR.
- 用于手术镇静的雷米马佐拉姆的使用.
- 用于PR逆转的弗卢马泽尼尔的管理.
主要成果:
- 在Remimazolam给药后,患者经历了一个矛盾的反应.
- 弗卢马泽尼尔有效且快速地扭转了矛盾反应症状.
- 这种情况表明GABAergic功能障碍与PR风险增加之间存在潜在联系.
结论:
- 双相情感障碍中的GABAergic功能障碍可能会增加对诸如雷米马佐拉姆之类的二类药物的悖论性反应的风险.
- 临床医生应谨慎行事,并为PR管理做好准备,在给双相情感障碍患者服用类时.
- 弗卢马泽尼尔是雷米马佐拉姆诱导的悖论性反应的有效解药.
相关概念视频
Mania and Antimanic Drugs: Overview
526
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
526
Psychosis: Goals of Pharmacotherapy
441
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
441
Bipolar Disorder
591
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
591
Antidepressant Drugs: MAOIs and Other Agents
770
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
770
REM Sleep Behavior Disorder
1.3K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
1.3K
Psychosis and Antipsychotic Drugs: Overview
776
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
776


